Deksametazon (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Deksametazon" in Turkish language version.

refsWebsite

Global rank Turkish rank

60web.archive.org

1^st place

47nih.gov

4^th place

11^th place

39doi.org

2^nd place

4^th place

6archive.org

6^th place

5europa.eu

68^th place

79^th place

5books.google.com

3^rd place

5^th place

5who.int

195^th place

162^nd place

4tga.gov.au

3,984^th place

3,256^th place

2drugs.com

399^th place

156^th place

2handle.net

102^nd place

447^th place

2clincalc.com

3,912^th place

2,106^th place

2medicines.org.uk

3,823^rd place

3,999^th place

2reuters.com

49^th place

74^th place

1fda.gov

447^th place

858^th place

1paramedic-info.com

low place

1ashpublications.org

low place

1mayoclinic.org

1,610^th place

1,902^nd place

1nejm.org

2,374^th place

1,854^th place

1sps.nhs.uk

low place

1idsociety.org

low place

1ox.ac.uk

613^th place

607^th place

1jamanetwork.com

2,650^th place

9,802^nd place

1archive.today

14^th place

20^th place

1canada.ca

1,712^th place

4,961^st place

1annals.org

low place

7,770^th place

1time.com

61^st place

109^th place

1operationalmedicine.org

low place

1medscape.com

719^th place

582^nd place

1harvard.edu

18^th place

47^th place

1targetcivils.in

low place

1gpni.co.uk

low place

1bmj.com

1,226^th place

1,421^st place

1bbc.co.uk

8^th place

25^th place

1wada-ama.org

9,542^nd place

low place

1wedgewoodpharmacy.com

low place

annals.org

Chrousos GP, Detera-Wadleigh SD, Karl M (December 1993). "Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113-24. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. 14 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Temmuz 2020.

archive.org

Wilkinson IB (13 Temmuz 2017). Oxford Handbook of Clinical Medicine. OUP Oxford. s. 176. ISBN 978-0-19-968990-3.
Schmelzeisen R, Frölich JC (1993). "Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth". European Journal of Clinical Pharmacology. 44 (3): 275-77. doi:10.1007/BF00271371. PMID 8491244.
Holte K, Kehlet H (November 2002). "Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications". Journal of the American College of Surgeons. 195 (5): 694-712. doi:10.1016/s1072-7515(02)01491-6. PMID 12437261.
Bloom SL, Sheffield JS, McIntire DD, Leveno KJ (April 2001). "Antenatal dexamethasone and decreased birth weight". Obstetrics and Gynecology. 97 (4): 485-90. doi:10.1016/S0029-7844(00)01206-0. PMID 11275014.
Kovac AL (May 2006). "Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies". The Annals of Pharmacotherapy. 40 (5): 873-87. doi:10.1345/aph.1G338. PMID 16670361.
Antignac JP, Le Bizec B, Monteau F, Andre F (January 2002). "Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69-75. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.

archive.today

Public Health Agency of Canada (23 Kasım 2020). "Ad-hoc COVID-19 Clinical Pharmacology Task Group: Statement on dexamethasone". Government of Canada. 27 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Nisan 2022.

ashpublications.org

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (January 2010). "International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168-86. doi:10.1182/blood-2009-06-225565. PMID 19846889. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

bbc.co.uk

Dummett M (30 Mayıs 2010). "Bangladesh's dark brothel steroid secret". BBC News Online. 22 Şubat 2012 tarihinde kaynağından arşivlendi.

bmj.com

Mahase E (June 2020). "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. doi:10.1136/bmj.m2512. PMID 32576548. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

books.google.com

Rankovic Z, Hargreaves R, Bingham M (2012). Drug discovery and medicinal chemistry for psychiatric disorders. Cambridge: Royal Society of Chemistry. s. 286. ISBN 9781849733656. 5 Mart 2016 tarihinde kaynağından arşivlendi.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. s. 485. ISBN 9783527607495. 16 Ekim 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Longo, Dan; Fauci, Anthony; Kasper, Dennis; Hauser, Stephen; Jameson, J.; Loscalzo, Joseph (22 Temmuz 2011). Harrison's Principles of Internal Medicine, 18th Edition (İtalyanca). McGraw Hill Professional. s. 3035. ISBN 978-0-07-174890-2. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Elks J (14 Kasım 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ss. 366-. ISBN 978-1-4757-2085-3. 15 Şubat 2017 tarihinde kaynağından arşivlendi.
Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ss. 310-. ISBN 978-3-88763-075-1. 24 Ağustos 2017 tarihinde kaynağından arşivlendi.

canada.ca

Public Health Agency of Canada (23 Kasım 2020). "Ad-hoc COVID-19 Clinical Pharmacology Task Group: Statement on dexamethasone". Government of Canada. 27 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Nisan 2022.

clincalc.com

"The Top 300 of 2020". ClinCalc. 16 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Dexamethasone – Drug Usage Statistics". ClinCalc. 15 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.

doi.org

Jobe AH, Milad MA, Peppard T, Jusko WJ (March 2020). "Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India". Clinical and Translational Science. 13 (2): 391-99. doi:10.1111/cts.12724. PMC 7070803 $2. PMID 31808984.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (January 2010). "International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168-86. doi:10.1182/blood-2009-06-225565. PMID 19846889. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Schmelzeisen R, Frölich JC (1993). "Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth". European Journal of Clinical Pharmacology. 44 (3): 275-77. doi:10.1007/BF00271371. PMID 8491244.
Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC, Garg SJ, Tang J (February 2016). "Corticosteroid implants for chronic non-infectious uveitis". Cochrane Database of Systematic Reviews. 2016 (2): CD010469. doi:10.1002/14651858.CD010469.pub2. PMC 5038923 $2. PMID 26866343. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Emami S, Kitayama K, Coleman AL (June 2022). "Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 6 (6): CD012131. doi:10.1002/14651858.CD012131.pub3. PMC 9169535 $2. PMID 35665485.
Brouwer MC, McIntyre P, Prasad K, van de Beek D (September 2015). "Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews (9): CD004405. doi:10.1002/14651858.CD004405.pub5. PMC 6491272 $2. PMID 26362566. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Roila F, Ballatori E, Ruggeri B, DeAngelis V (May 2000). "Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554-59. doi:10.1056/NEJM200005253422102. PMID 10824073. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Holte K, Kehlet H (November 2002). "Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications". Journal of the American College of Surgeons. 195 (5): 694-712. doi:10.1016/s1072-7515(02)01491-6. PMID 12437261.
Jessurun CA, Hulsbergen AF, Cho LD, Aglio LS, Nandoe Tewarie RD, Broekman ML (September 2019). "Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249-264. doi:10.1007/s11060-019-03238-4. PMC 6700052 $2. PMID 31346902. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LC, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JP, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini V, Veiga VC, Webb S, Marshall JC, ve diğerleri. (The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group) (September 2020). "Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330-1341. doi:10.1001/jama.2020.17023. PMC 7489434 $2. PMID 32876694. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Prescott HC, Rice TW (September 2020). "Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292-1295. doi:10.1001/jama.2020.16747. PMID 32876693. 3 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PW, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J (August 2022). "Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set". Critical Care. 26 (1): 236. doi:10.1186/s13054-022-04108-8. PMC 9347163 $2. PMID 35922860.
Meynaar IA, van Rijn S, Ottens TH, van Burgel ND, van Nieuwkoop C (July 2022). "Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists". Intensive Care Medicine. 48 (7): 954-957. doi:10.1007/s00134-022-06750-w. PMC 9171741 $2. PMID 35670819.
Scaravilli V, Guzzardella A, Madotto F, Beltrama V, Muscatello A, Bellani G, Monti G, Greco M, Pesenti A, Bandera A, Grasselli G (June 2022). "Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study". Critical Care. 26 (1): 176. doi:10.1186/s13054-022-04049-2. PMC 9191402 $2. PMID 35698155.
Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, Cuchet-Lourenço D, Lux J, Sharma-Hajela S, Ravenhill B, Hamed I, Heales L, Mahroof R, Soderholm A, Forrest S, Sridhar S, Brown NM, Baker S, Navapurkar V, Dougan G, Bartholdson Scott J, Conway Morris A (January 2021). "Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. doi:10.1186/s13054-021-03460-5. PMC 7797892 $2. PMID 33430915.
Sinha S, Rosin NL, Arora R, Labit E, Jaffer A, Cao L, Farias R, Nguyen AP, de Almeida LG, Dufour A, Bromley A, McDonald B, Gillrie MR, Fritzler MJ, Yipp BG, Biernaskie J (January 2022). "Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine. 28 (1): 201-211. doi:10.1038/s41591-021-01576-3. PMC 8799469 $2. PMID 34782790.
Chrousos GP, Detera-Wadleigh SD, Karl M (December 1993). "Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113-24. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. 14 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Temmuz 2020.
Charmandari E, Kino T, Ichijo T, Chrousos GP (May 2008). "Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder". The Journal of Clinical Endocrinology and Metabolism. 93 (5): 1563-72. doi:10.1210/jc.2008-0040. PMC 2386273 $2. PMID 18319312.
Bloom SL, Sheffield JS, McIntire DD, Leveno KJ (April 2001). "Antenatal dexamethasone and decreased birth weight". Obstetrics and Gynecology. 97 (4): 485-90. doi:10.1016/S0029-7844(00)01206-0. PMID 11275014.
Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S (June 2012). "Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881-83. doi:10.1210/jc.2012-1222. PMID 22466333. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S (February 2007). "Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542-48. doi:10.1210/jc.2006-1340. PMID 17148562. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Lajic S, Nordenström A, Hirvikoski T (2011). "Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency". Endocrine Development. 20: 96-105. doi:10.1159/000321228. ISBN 978-3-8055-9643-5. PMID 21164263.
Simancas-Racines D, Arevalo-Rodriguez I, Osorio D, Franco JV, Xu Y, Hidalgo R (June 2018). "Interventions for treating acute high altitude illness". Cochrane Database Syst Rev. 6 (12): CD009567. doi:10.1002/14651858.CD009567.pub2. PMC 6513207 $2. PMID 29959871.
Eledrisi MS (April 2007). "First-line therapy for hypertension". Annals of Internal Medicine. 146 (8): 615. doi:10.7326/0003-4819-146-8-200704170-00021. PMID 17438328.
Grape S, Usmanova I, Kirkham KR, Albrecht E (April 2018). "Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480-89. doi:10.1111/anae.14166. PMID 29226971. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Kovac AL (May 2006). "Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies". The Annals of Pharmacotherapy. 40 (5): 873-87. doi:10.1345/aph.1G338. PMID 16670361.
Sadeghirad B, Siemieniuk RA, Brignardello-Petersen R, Papola D, Lytvyn L, Vandvik PO, Merglen A, Guyatt GH, Agoritsas T (September 2017). "Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. doi:10.1136/bmj.j3887. PMC 5605780 $2. PMID 28931508.
Cole TJ (2006). "Glucocorticoid action and the development of selective glucocorticoid receptor ligands". Biotechnol Annu Rev. 12: 269-300. doi:10.1016/S1387-2656(06)12008-6. PMID 17045197.
Meijer OC, de Kloet ER (March 2017). "A Refill for the Brain Mineralocorticoid Receptor: The Benefit of Cortisol Add-On to Dexamethasone Therapy". Endocrinology. 158 (3): 448-454. doi:10.1210/en.2016-1495. PMID 27967238.
Khan MO, Park KK, Lee HJ (2005). "Antedrugs: an approach to safer drugs". Current Medicinal Chemistry. 12 (19): 2227-39. doi:10.2174/0929867054864840. PMID 16178782.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (August 2013). "A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy". Allergy, Asthma, and Clinical Immunology. 9 (1): 30. doi:10.1186/1710-1492-9-30. PMC 3765115 $2. PMID 23947590.
De Kloet ER (October 1997). "Why Dexamethasone Poorly Penetrates in Brain". Stress. 2 (1): 13-20. doi:10.3109/10253899709014734. PMID 9787252.
Raynor JW, Minor W, Chruszcz M (2007). "Dexamethasone at 119 K". Acta Crystallographica Section E. 63 (6): o2791-93. doi:10.1107/S1600536807020806.
Antignac JP, Le Bizec B, Monteau F, Andre F (January 2002). "Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69-75. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.
Arth GE, Fried J, Johnston DBR, Hoff DR, Sarett HL, Silber RH, Stoerk HC, Winter CA (1958). "16-Methylated steroids. II. 16α-Methyl analogs of cortisone, a new group of anti-inflammatory steroids. 9α-Halo derivatives". Journal of the American Chemical Society. 80 (12): 3161-63. doi:10.1021/ja01545a063.
Taub D, Hoffsommer RD, Slates HL, lWendler NL (1958). "16β-Methyl cortical steroids". Journal of the American Chemical Society. 80 (16): 4435. doi:10.1021/ja01549a095.
Mahase E (June 2020). "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. doi:10.1136/bmj.m2512. PMID 32576548. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (July 2020). "Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693-704. doi:10.1056/NEJMoa2021436. PMC 7383595 $2. PMID 32678530. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (February 2021). "Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693-704. doi:10.1056/NEJMoa2021436. PMC 7383595 $2. PMID 32678530. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

drugs.com

"Dexamethasone Use During Pregnancy". Drugs.com. 17 Mayıs 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Haziran 2016. Dexamethasone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
"Dexamethasone". The American Society of Health-System Pharmacists. 31 Ağustos 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Temmuz 2015.

europa.eu

ema.europa.eu

"Ozurdex EPAR". European Medicines Agency (EMA). 17 Eylül 2018. 27 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ekim 2020.
"Neofordex EPAR". European Medicines Agency (EMA). 27 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ekim 2020. ^{[ölü/kırık bağlantı]}
"EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation". European Medicines Agency (EMA) (Basın açıklaması). 18 Eylül 2020. 14 Şubat 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Eylül 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support". European Medicines Agency (EMA) (Basın açıklaması). 24 Temmuz 2020. 30 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Temmuz 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"EMA receives application for marketing authorisation of Dexamethasone Taw COVID-19". European Medicines Agency (EMA). 2 Eylül 2020. 3 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 2 Eylül 2020.

fda.gov

accessdata.fda.gov

"Drugs@FDA: Dexamethasone". U.S. Food and Drug Administration (FDA). 30 Kasım 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.

gpni.co.uk

"Dexamethasone in COVID-19" (PDF). www.gpni.co.uk. 16 Haziran 2020. 17 Haziran 2020 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 18 Haziran 2020.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Cenevre: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
World Health Organization (2020). Corticosteroids for COVID-19: living guidance, 2 September 2020. World Health Organization. hdl:10665/334125. WHO/2019-nCoV/Corticosteroids/2020.1. 11 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

harvard.edu

adsabs.harvard.edu

Antignac JP, Le Bizec B, Monteau F, Andre F (January 2002). "Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69-75. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.

idsociety.org

"COVID-19 Guideline, Part 1: Treatment and Management". Infectious Diseases Society of America. 12 Nisan 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Temmuz 2020. Recommendation 4. Among hospitalized people with severe* COVID-19, the IDSA guideline panel suggests glucocorticoids rather than no glucocorticoids. (Conditional recommendation, Moderate certainty of evidence)
Remark: Dexamethasone 6 mg IV or PO for 10 days (or until discharge if earlier) or equivalent glucocorticoid dose may be substituted if dexamethasone unavailable. Equivalent total daily doses of alternative glucocorticoids to dexamethasone 6 mg daily are methylprednisolone 32 mg and prednisone 40 mg.
Recommendation 5. Among hospitalized people with COVID-19 without hypoxemia requiring supplemental oxygen, the IDSA guideline panel suggests against the use of glucocorticoids. (Conditional recommendation, Low certainty of evidence)

jamanetwork.com

Prescott HC, Rice TW (September 2020). "Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292-1295. doi:10.1001/jama.2020.16747. PMID 32876693. 3 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

mayoclinic.org

"Croup – Diagnosis & Treatment". Mayo Clinic. 10 Ekim 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Ekim 2017. Dexamethasone is usually recommended because of its long-lasting effects (up to 72 hours).

medicines.org.uk

"Dexamethasone Tablet BP 2.0 mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 26 Ocak 2018. 17 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Haziran 2020.
"Dexamethasone 4.0 mg/ml injection – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 4 Aralık 2013. 8 Mayıs 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2013.

medscape.com

reference.medscape.com

"Decadron, Dexamethasone Intensol (dexamethasone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 12 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2013.

nejm.org

Roila F, Ballatori E, Ruggeri B, DeAngelis V (May 2000). "Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554-59. doi:10.1056/NEJM200005253422102. PMID 10824073. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

nih.gov

ncbi.nlm.nih.gov

Dogra P, Vijayashankar NP (14 Eylül 2020). "Dexamethasone Suppression Test". StatPearls (September 14, 2020). PMID 31194457.
Jobe AH, Milad MA, Peppard T, Jusko WJ (March 2020). "Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India". Clinical and Translational Science. 13 (2): 391-99. doi:10.1111/cts.12724. PMC 7070803 $2. PMID 31808984.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (January 2010). "International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168-86. doi:10.1182/blood-2009-06-225565. PMID 19846889. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Schmelzeisen R, Frölich JC (1993). "Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth". European Journal of Clinical Pharmacology. 44 (3): 275-77. doi:10.1007/BF00271371. PMID 8491244.
Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC, Garg SJ, Tang J (February 2016). "Corticosteroid implants for chronic non-infectious uveitis". Cochrane Database of Systematic Reviews. 2016 (2): CD010469. doi:10.1002/14651858.CD010469.pub2. PMC 5038923 $2. PMID 26866343. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Emami S, Kitayama K, Coleman AL (June 2022). "Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 6 (6): CD012131. doi:10.1002/14651858.CD012131.pub3. PMC 9169535 $2. PMID 35665485.
Brouwer MC, McIntyre P, Prasad K, van de Beek D (September 2015). "Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews (9): CD004405. doi:10.1002/14651858.CD004405.pub5. PMC 6491272 $2. PMID 26362566. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Roila F, Ballatori E, Ruggeri B, DeAngelis V (May 2000). "Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554-59. doi:10.1056/NEJM200005253422102. PMID 10824073. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Holte K, Kehlet H (November 2002). "Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications". Journal of the American College of Surgeons. 195 (5): 694-712. doi:10.1016/s1072-7515(02)01491-6. PMID 12437261.
Jessurun CA, Hulsbergen AF, Cho LD, Aglio LS, Nandoe Tewarie RD, Broekman ML (September 2019). "Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249-264. doi:10.1007/s11060-019-03238-4. PMC 6700052 $2. PMID 31346902. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Harousseau JL, Attal M, Leleu X, Troncy J, Pegourie B, Stoppa AM, Hulin C, Benboubker L, Fuzibet JG, Renaud M, Moreau P, Avet-Loiseau H (November 2006). "Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study". Haematologica. 91 (11): 1498-505. PMID 17043025.
Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LC, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JP, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini V, Veiga VC, Webb S, Marshall JC, ve diğerleri. (The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group) (September 2020). "Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330-1341. doi:10.1001/jama.2020.17023. PMC 7489434 $2. PMID 32876694. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Prescott HC, Rice TW (September 2020). "Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292-1295. doi:10.1001/jama.2020.16747. PMID 32876693. 3 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PW, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J (August 2022). "Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set". Critical Care. 26 (1): 236. doi:10.1186/s13054-022-04108-8. PMC 9347163 $2. PMID 35922860.
Meynaar IA, van Rijn S, Ottens TH, van Burgel ND, van Nieuwkoop C (July 2022). "Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists". Intensive Care Medicine. 48 (7): 954-957. doi:10.1007/s00134-022-06750-w. PMC 9171741 $2. PMID 35670819.
Scaravilli V, Guzzardella A, Madotto F, Beltrama V, Muscatello A, Bellani G, Monti G, Greco M, Pesenti A, Bandera A, Grasselli G (June 2022). "Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study". Critical Care. 26 (1): 176. doi:10.1186/s13054-022-04049-2. PMC 9191402 $2. PMID 35698155.
Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, Cuchet-Lourenço D, Lux J, Sharma-Hajela S, Ravenhill B, Hamed I, Heales L, Mahroof R, Soderholm A, Forrest S, Sridhar S, Brown NM, Baker S, Navapurkar V, Dougan G, Bartholdson Scott J, Conway Morris A (January 2021). "Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. doi:10.1186/s13054-021-03460-5. PMC 7797892 $2. PMID 33430915.
Sinha S, Rosin NL, Arora R, Labit E, Jaffer A, Cao L, Farias R, Nguyen AP, de Almeida LG, Dufour A, Bromley A, McDonald B, Gillrie MR, Fritzler MJ, Yipp BG, Biernaskie J (January 2022). "Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine. 28 (1): 201-211. doi:10.1038/s41591-021-01576-3. PMC 8799469 $2. PMID 34782790.
Chrousos GP, Detera-Wadleigh SD, Karl M (December 1993). "Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113-24. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. 14 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Temmuz 2020.
Charmandari E, Kino T, Ichijo T, Chrousos GP (May 2008). "Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder". The Journal of Clinical Endocrinology and Metabolism. 93 (5): 1563-72. doi:10.1210/jc.2008-0040. PMC 2386273 $2. PMID 18319312.
Bloom SL, Sheffield JS, McIntire DD, Leveno KJ (April 2001). "Antenatal dexamethasone and decreased birth weight". Obstetrics and Gynecology. 97 (4): 485-90. doi:10.1016/S0029-7844(00)01206-0. PMID 11275014.
Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S (June 2012). "Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881-83. doi:10.1210/jc.2012-1222. PMID 22466333. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S (February 2007). "Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542-48. doi:10.1210/jc.2006-1340. PMID 17148562. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Lajic S, Nordenström A, Hirvikoski T (2011). "Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency". Endocrine Development. 20: 96-105. doi:10.1159/000321228. ISBN 978-3-8055-9643-5. PMID 21164263.
Simancas-Racines D, Arevalo-Rodriguez I, Osorio D, Franco JV, Xu Y, Hidalgo R (June 2018). "Interventions for treating acute high altitude illness". Cochrane Database Syst Rev. 6 (12): CD009567. doi:10.1002/14651858.CD009567.pub2. PMC 6513207 $2. PMID 29959871.
Eledrisi MS (April 2007). "First-line therapy for hypertension". Annals of Internal Medicine. 146 (8): 615. doi:10.7326/0003-4819-146-8-200704170-00021. PMID 17438328.
Grape S, Usmanova I, Kirkham KR, Albrecht E (April 2018). "Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480-89. doi:10.1111/anae.14166. PMID 29226971. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Kovac AL (May 2006). "Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies". The Annals of Pharmacotherapy. 40 (5): 873-87. doi:10.1345/aph.1G338. PMID 16670361.
Sadeghirad B, Siemieniuk RA, Brignardello-Petersen R, Papola D, Lytvyn L, Vandvik PO, Merglen A, Guyatt GH, Agoritsas T (September 2017). "Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. doi:10.1136/bmj.j3887. PMC 5605780 $2. PMID 28931508.
Cole TJ (2006). "Glucocorticoid action and the development of selective glucocorticoid receptor ligands". Biotechnol Annu Rev. 12: 269-300. doi:10.1016/S1387-2656(06)12008-6. PMID 17045197.
Meijer OC, de Kloet ER (March 2017). "A Refill for the Brain Mineralocorticoid Receptor: The Benefit of Cortisol Add-On to Dexamethasone Therapy". Endocrinology. 158 (3): 448-454. doi:10.1210/en.2016-1495. PMID 27967238.
De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP (2000). "Endotext". Glucocorticoid Therapy and Adrenal Suppression. MDText.com. PMID 25905379.
Khan MO, Park KK, Lee HJ (2005). "Antedrugs: an approach to safer drugs". Current Medicinal Chemistry. 12 (19): 2227-39. doi:10.2174/0929867054864840. PMID 16178782.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (August 2013). "A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy". Allergy, Asthma, and Clinical Immunology. 9 (1): 30. doi:10.1186/1710-1492-9-30. PMC 3765115 $2. PMID 23947590.
De Kloet ER (October 1997). "Why Dexamethasone Poorly Penetrates in Brain". Stress. 2 (1): 13-20. doi:10.3109/10253899709014734. PMID 9787252.
Antignac JP, Le Bizec B, Monteau F, Andre F (January 2002). "Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69-75. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.
Mahase E (June 2020). "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. doi:10.1136/bmj.m2512. PMID 32576548. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (July 2020). "Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693-704. doi:10.1056/NEJMoa2021436. PMC 7383595 $2. PMID 32678530. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (February 2021). "Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693-704. doi:10.1056/NEJMoa2021436. PMC 7383595 $2. PMID 32678530. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

dailymed.nlm.nih.gov

"Ozurdex- dexamethasone implant". DailyMed. 30 Ekim 2020. 27 Mart 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Dexamethasone sodium phosphate solution/ drops". DailyMed. 31 Temmuz 2020. 27 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Dexycu- dexamethasone injection, suspension". DailyMed. 20 Aralık 2021. 27 Mart 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Dexamethasone tablet [ECR Pharmaceuticals]". DailyMed. ECR Pharmaceuticals. December 2010. 13 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2013.

pubmed.ncbi.nlm.nih.gov

Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S (June 2012). "Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881-83. doi:10.1210/jc.2012-1222. PMID 22466333. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S (February 2007). "Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542-48. doi:10.1210/jc.2006-1340. PMID 17148562. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Grape S, Usmanova I, Kirkham KR, Albrecht E (April 2018). "Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480-89. doi:10.1111/anae.14166. PMID 29226971. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.

covid19treatmentguidelines.nih.gov

"Corticosteroids". COVID-19 Treatment Guidelines. National Institutes of Health. 19 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 12 Temmuz 2020.

operationalmedicine.org

Cymerman A, Rock PB (1994). Medical Problems in High Mountain Environments. A Handbook for Medical Officers (PDF). USARIEM-TN94-2. US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine Division Technical Report. 17 Haziran 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 17 Haziran 2020.

ox.ac.uk

"Dexamethasone reduces death in hospitalized people with severe respiratory complications of COVID-19". University of Oxford. 16 Haziran 2020. 16 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Haziran 2020.

paramedic-info.com

Till J. "Paramedic Clinical Training Aid". 31 Mart 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 30 Ağustos 2011.

reuters.com

"Important to use dexamethasone only for serious COVID cases – WHO". 17 Haziran 2020. 17 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Haziran 2020.
"EMA to review results from study testing common steroid drug against COVID-19". Reuters. 24 Temmuz 2020. 27 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Temmuz 2020.

sps.nhs.uk

"Dexamethasone and COVID-19". SPS – Specialist Pharmacy Service. 22 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Temmuz 2020.

targetcivils.in

"Dexamethasone". 17 Haziran 2020. 1 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Haziran 2020.

tga.gov.au

"DEXAMETHASONE JUNO (Juno Pharmaceuticals Pty Ltd)". Department of Health and Aged Care. 18 Mart 2023 tarihinde kaynağından arşivlendi.
"Prescribing medicines in pregnancy database". Australian Government. 3 Mart 2014. 8 Nisan 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Nisan 2014. Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.

ebs.tga.gov.au

"Product Information Dexamethsone (dexamethasone)". TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 10 Ağustos 2010. 10 Temmuz 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Aralık 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)
"Product Information Dexmethsone Injection". TGA eBusiness ServicesAspen Pharmacare Australia Pty Ltd. Aspen Pharmacare Australia Pty Ltd. 2 Mart 2011. 10 Temmuz 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Aralık 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)

time.com

content.time.com

Elton C (18 Haziran 2010). "A Prenatal Treatment Raises Questions of Medical Ethics". 31 Ağustos 2016 tarihinde kaynağından arşivlendi – content.time.com vasıtasıyla.

wada-ama.org

"Prohibited In-Competition: Glucocorticoids". World Anti-Doping Agency. 16 Temmuz 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Temmuz 2018.

web.archive.org

"Dexamethasone Use During Pregnancy". Drugs.com. 17 Mayıs 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 9 Haziran 2016. Dexamethasone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
"DEXAMETHASONE JUNO (Juno Pharmaceuticals Pty Ltd)". Department of Health and Aged Care. 18 Mart 2023 tarihinde kaynağından arşivlendi.
"Ozurdex- dexamethasone implant". DailyMed. 30 Ekim 2020. 27 Mart 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Dexamethasone sodium phosphate solution/ drops". DailyMed. 31 Temmuz 2020. 27 Ocak 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Dexycu- dexamethasone injection, suspension". DailyMed. 20 Aralık 2021. 27 Mart 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Ozurdex EPAR". European Medicines Agency (EMA). 17 Eylül 2018. 27 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ekim 2020.
"Neofordex EPAR". European Medicines Agency (EMA). 27 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 24 Ekim 2020. ^{[ölü/kırık bağlantı]}
"Dexamethasone". The American Society of Health-System Pharmacists. 31 Ağustos 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Temmuz 2015.
"Prescribing medicines in pregnancy database". Australian Government. 3 Mart 2014. 8 Nisan 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Nisan 2014. Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.
"Drugs@FDA: Dexamethasone". U.S. Food and Drug Administration (FDA). 30 Kasım 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
Rankovic Z, Hargreaves R, Bingham M (2012). Drug discovery and medicinal chemistry for psychiatric disorders. Cambridge: Royal Society of Chemistry. s. 286. ISBN 9781849733656. 5 Mart 2016 tarihinde kaynağından arşivlendi.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. s. 485. ISBN 9783527607495. 16 Ekim 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"The Top 300 of 2020". ClinCalc. 16 Mart 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Dexamethasone – Drug Usage Statistics". ClinCalc. 15 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
Till J. "Paramedic Clinical Training Aid". 31 Mart 2012 tarihinde kaynağından arşivlendi. Erişim tarihi: 30 Ağustos 2011.
Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (January 2010). "International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168-86. doi:10.1182/blood-2009-06-225565. PMID 19846889. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"Croup – Diagnosis & Treatment". Mayo Clinic. 10 Ekim 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Ekim 2017. Dexamethasone is usually recommended because of its long-lasting effects (up to 72 hours).
Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC, Garg SJ, Tang J (February 2016). "Corticosteroid implants for chronic non-infectious uveitis". Cochrane Database of Systematic Reviews. 2016 (2): CD010469. doi:10.1002/14651858.CD010469.pub2. PMC 5038923 $2. PMID 26866343. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Brouwer MC, McIntyre P, Prasad K, van de Beek D (September 2015). "Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews (9): CD004405. doi:10.1002/14651858.CD004405.pub5. PMC 6491272 $2. PMID 26362566. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Roila F, Ballatori E, Ruggeri B, DeAngelis V (May 2000). "Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554-59. doi:10.1056/NEJM200005253422102. PMID 10824073. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Jessurun CA, Hulsbergen AF, Cho LD, Aglio LS, Nandoe Tewarie RD, Broekman ML (September 2019). "Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249-264. doi:10.1007/s11060-019-03238-4. PMC 6700052 $2. PMID 31346902. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"Dexamethasone and COVID-19". SPS – Specialist Pharmacy Service. 22 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Temmuz 2020.
"Corticosteroids". COVID-19 Treatment Guidelines. National Institutes of Health. 19 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 12 Temmuz 2020.
"COVID-19 Guideline, Part 1: Treatment and Management". Infectious Diseases Society of America. 12 Nisan 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Temmuz 2020. Recommendation 4. Among hospitalized people with severe* COVID-19, the IDSA guideline panel suggests glucocorticoids rather than no glucocorticoids. (Conditional recommendation, Moderate certainty of evidence)
Remark: Dexamethasone 6 mg IV or PO for 10 days (or until discharge if earlier) or equivalent glucocorticoid dose may be substituted if dexamethasone unavailable. Equivalent total daily doses of alternative glucocorticoids to dexamethasone 6 mg daily are methylprednisolone 32 mg and prednisone 40 mg.
Recommendation 5. Among hospitalized people with COVID-19 without hypoxemia requiring supplemental oxygen, the IDSA guideline panel suggests against the use of glucocorticoids. (Conditional recommendation, Low certainty of evidence)
World Health Organization (2020). Corticosteroids for COVID-19: living guidance, 2 September 2020. World Health Organization. hdl:10665/334125. WHO/2019-nCoV/Corticosteroids/2020.1. 11 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"Dexamethasone reduces death in hospitalized people with severe respiratory complications of COVID-19". University of Oxford. 16 Haziran 2020. 16 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Haziran 2020.
Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LC, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JP, Horby P, Jüni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Møller MH, Perner A, Petersen MW, Savovic J, Tomazini V, Veiga VC, Webb S, Marshall JC, ve diğerleri. (The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group) (September 2020). "Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330-1341. doi:10.1001/jama.2020.17023. PMC 7489434 $2. PMID 32876694. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Prescott HC, Rice TW (September 2020). "Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292-1295. doi:10.1001/jama.2020.16747. PMID 32876693. 3 Aralık 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation". European Medicines Agency (EMA) (Basın açıklaması). 18 Eylül 2020. 14 Şubat 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 21 Eylül 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
Chrousos GP, Detera-Wadleigh SD, Karl M (December 1993). "Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113-24. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. 14 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Temmuz 2020.
Longo, Dan; Fauci, Anthony; Kasper, Dennis; Hauser, Stephen; Jameson, J.; Loscalzo, Joseph (22 Temmuz 2011). Harrison's Principles of Internal Medicine, 18th Edition (İtalyanca). McGraw Hill Professional. s. 3035. ISBN 978-0-07-174890-2. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Elton C (18 Haziran 2010). "A Prenatal Treatment Raises Questions of Medical Ethics". 31 Ağustos 2016 tarihinde kaynağından arşivlendi – content.time.com vasıtasıyla.
Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S (June 2012). "Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881-83. doi:10.1210/jc.2012-1222. PMID 22466333. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S (February 2007). "Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542-48. doi:10.1210/jc.2006-1340. PMID 17148562. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Cymerman A, Rock PB (1994). Medical Problems in High Mountain Environments. A Handbook for Medical Officers (PDF). USARIEM-TN94-2. US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine Division Technical Report. 17 Haziran 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 17 Haziran 2020.
Grape S, Usmanova I, Kirkham KR, Albrecht E (April 2018). "Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480-89. doi:10.1111/anae.14166. PMID 29226971. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"Decadron, Dexamethasone Intensol (dexamethasone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. 12 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2013.
"Product Information Dexamethsone (dexamethasone)". TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 10 Ağustos 2010. 10 Temmuz 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Aralık 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)
"Product Information Dexmethsone Injection". TGA eBusiness ServicesAspen Pharmacare Australia Pty Ltd. Aspen Pharmacare Australia Pty Ltd. 2 Mart 2011. 10 Temmuz 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 11 Aralık 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)
"Dexamethasone tablet [ECR Pharmaceuticals]". DailyMed. ECR Pharmaceuticals. December 2010. 13 Aralık 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2013.
"Dexamethasone Tablet BP 2.0 mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 26 Ocak 2018. 17 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 17 Haziran 2020.
"Dexamethasone 4.0 mg/ml injection – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 4 Aralık 2013. 8 Mayıs 2015 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Aralık 2013.
Elks J (14 Kasım 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ss. 366-. ISBN 978-1-4757-2085-3. 15 Şubat 2017 tarihinde kaynağından arşivlendi.
Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ss. 310-. ISBN 978-3-88763-075-1. 24 Ağustos 2017 tarihinde kaynağından arşivlendi.
"Dexamethasone". 17 Haziran 2020. 1 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Haziran 2020.
"Dexamethasone in COVID-19" (PDF). www.gpni.co.uk. 16 Haziran 2020. 17 Haziran 2020 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 18 Haziran 2020.
Mahase E (June 2020). "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. doi:10.1136/bmj.m2512. PMID 32576548. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (July 2020). "Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693-704. doi:10.1056/NEJMoa2021436. PMC 7383595 $2. PMID 32678530. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (February 2021). "Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693-704. doi:10.1056/NEJMoa2021436. PMC 7383595 $2. PMID 32678530. 19 Kasım 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"Important to use dexamethasone only for serious COVID cases – WHO". 17 Haziran 2020. 17 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 18 Haziran 2020.
"WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization. 22 Haziran 2020. 22 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Haziran 2020.
"Q&A: Dexamethasone and COVID-19". World Health Organization (WHO). 24 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 12 Temmuz 2020.
"WHO updates clinical care guidance with corticosteroid recommendations". World Health Organization (WHO) (Basın açıklaması). 2 Eylül 2020. 6 Mayıs 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support". European Medicines Agency (EMA) (Basın açıklaması). 24 Temmuz 2020. 30 Ocak 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Temmuz 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"EMA to review results from study testing common steroid drug against COVID-19". Reuters. 24 Temmuz 2020. 27 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Temmuz 2020.
"EMA receives application for marketing authorisation of Dexamethasone Taw COVID-19". European Medicines Agency (EMA). 2 Eylül 2020. 3 Eylül 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 2 Eylül 2020.
"Dexamethasone for Accelerating Lung Maturation in Preterm Babies" (PDF). 22 Aralık 2015 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 29 Temmuz 2015.
Dummett M (30 Mayıs 2010). "Bangladesh's dark brothel steroid secret". BBC News Online. 22 Şubat 2012 tarihinde kaynağından arşivlendi.
"Prohibited In-Competition: Glucocorticoids". World Anti-Doping Agency. 16 Temmuz 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Temmuz 2018.
"Trichlormethiazide and Dexamethasone for veterinary use". Wedgewood Pharmacy. 12 Aralık 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Ocak 2008.

wedgewoodpharmacy.com

"Trichlormethiazide and Dexamethasone for veterinary use". Wedgewood Pharmacy. 12 Aralık 2007 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Ocak 2008.

who.int

World Health Organization (2020). Corticosteroids for COVID-19: living guidance, 2 September 2020. World Health Organization. hdl:10665/334125. WHO/2019-nCoV/Corticosteroids/2020.1. 11 Ekim 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 19 Kasım 2022.
"WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization. 22 Haziran 2020. 22 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 26 Haziran 2020.
"Q&A: Dexamethasone and COVID-19". World Health Organization (WHO). 24 Haziran 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 12 Temmuz 2020.
"WHO updates clinical care guidance with corticosteroid recommendations". World Health Organization (WHO) (Basın açıklaması). 2 Eylül 2020. 6 Mayıs 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Mart 2022.
"Dexamethasone for Accelerating Lung Maturation in Preterm Babies" (PDF). 22 Aralık 2015 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 29 Temmuz 2015.